The asset management arm of India's Kotak Mahindra Group said it will invest 10.70 billion rupees ($129 million) in Biocon Ltd to help it fund its acquisition of Viatris Inc's biosimilars business. In late November, Biocon Biologics completed...
Malaria No More (MNM) has signed a Memorandum of Understanding (MoU) with the Government of Odisha's Department of Health and Family Welfare to eradicate malaria from the state...
All Nippon Airways (ANA), the Japanese largest airline, and DoKaSch Temperature Solutions have signed a Master Rental Agreement. The German specialist for active temperature-controlled packaging solutions is henceforth providing its Opticooler....
The World Health Organization (WHO) has granted prequalification for the firm's varicella vaccine, Barycela, according to GC Biopharma, a leading provider of biopharmaceutical products in South Korea...
Gland Pharma announced today that it will invest Rs 400 crore to expand its existing facility in Genome Valley here to manufacture biologicals, biosimilars, antibodies, and recombinant insulin. According to a state government press release, the...
Clinical trials for BioNTech's cancer vaccines are expected to begin this year in the United Kingdom, marking an important step towards their possible sale on the open market, according to the German company's top executive, Ugur Sahin, in the...
Sun Pharmaceutical Industries Ltd., one of India's leading pharmaceutical companies, has announced the acquisition of a 26.09% stake in digital health startups Agatsa Software Pvt. Ltd. and Remidio Innovative Solutions Pvt. Ltd. The move is part...
AstraZeneca India announced that it has received approval from the country's drug regulator to market a drug to treat biliary tract cancer (BTC). Durvalumab has been approved by the Central Drugs Standard Control Organisation (CDSCO),...
Lupin Limited (Lupin) announced that the United States Food and Drug Administration (US FDA) has approved the Establishment Inspection Report (EIR) for its new injectable facility in Nagpur...
PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, announced that it will advance LYT-300 (oral allopregnanolone), a clinical therapeutic candidate in development as...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")